Noninvasive surveillance with multitarget stool DNA testing or fecal immunochemical testing (FIT) could potentially match colonoscopy for reducing long-term colorectal cancer (CRC) incidence and ...
A study published in JAMA found no correlation between intense colorectal cancer surveillance and increased detection or survival rates, Clinical Oncology News reports. Researchers analyzed 8,529 ...
Increased time spent on discussing testing for colorectal cancer (CRC) was associated with patient satisfaction in older adults. Adults aged 76 to 85 years were more likely to continue testing for ...
Serial circulating tumor DNA (ctDNA) testing showed limited clinical benefit in colorectal cancer (CRC) surveillance when frequent imaging is used. The study's retrospective design and small sample ...
Blood test for minimal residual disease (MRD) now covered to monitor for disease recurrence after curative intent treatment Tissue-free approach addresses need for cancer patients who have no tissue ...
Certain patients with inflammatory bowel disease, which includes ulcerative colitis and Crohn’s disease of the colon, have an increased risk of developing colorectal cancer compared to individuals ...
Interviews with 60 African American CRC survivors were recorded and transcribed. Compliance with surveillance guidelines was defined by disease stage and self-reported tests. Four coders (blind to ...
Metabolic syndrome and its components, including obesity and hypertension, significantly increase the risk for precancerous polyp recurrence.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results